Virtus Lifesci Biotech Etf Performance
| BBC Etf | USD 25.74 0.33 1.27% |
The entity has a beta of 2.1, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Virtus LifeSci will likely underperform.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Virtus LifeSci Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental drivers, Virtus LifeSci may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
1 | Bitcoin ETF Hits New 52-Week High - Yahoo Finance Australia | 02/15/2024 |
2 | Nigeria Government Demands 10B From Crypto Exchange Binance BBC - CoinDesk | 03/01/2024 |
3 | Half Year 2023 BNK Banking Corporation Ltd Earnings Call Transcript | 03/28/2024 |
| In Threey Sharp Ratio | -0.44 |
Virtus |
Virtus LifeSci Relative Risk vs. Return Landscape
If you would invest 2,389 in Virtus LifeSci Biotech on January 18, 2024 and sell it today you would earn a total of 218.00 from holding Virtus LifeSci Biotech or generate 9.13% return on investment over 90 days. Virtus LifeSci Biotech is generating 0.162% of daily returns assuming volatility of 2.179% on return distribution over 90 days investment horizon. In other words, 19% of etfs are less volatile than Virtus, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Virtus LifeSci Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Virtus LifeSci's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Virtus LifeSci Biotech, and traders can use it to determine the average amount a Virtus LifeSci's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0744
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BBC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.18 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Virtus LifeSci is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding it to a well-diversified portfolio.
Virtus LifeSci Fundamentals Growth
Virtus Etf prices reflect investors' perceptions of the future prospects and financial health of Virtus LifeSci, and Virtus LifeSci fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Virtus Etf performance.
| Price To Earning | 39.87 X | |||
| Price To Book | 1.75 X | |||
| Price To Sales | 1.99 X | |||
| Total Asset | 18.12 M | |||
About Virtus LifeSci Performance
To evaluate Virtus LifeSci Biotech Etf as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Virtus LifeSci generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Virtus Etf's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Virtus LifeSci Biotech market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Virtus's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.| Latest headline from gurufocus.com: Half Year 2023 BNK Banking Corporation Ltd Earnings Call Transcript | |
| Virtus LifeSci Biotech generated five year return of -2.0% | |
| This fund holds 98.9% of its assets under management (AUM) in equities |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.